Jefferies Downgrades LeMaitre Vascular to Hold, Raises Price Target to $67
Portfolio Pulse from richadhand@benzinga.com
Jefferies analyst Anthony Petrone has downgraded LeMaitre Vascular from Buy to Hold, while raising the price target from $63 to $67.
August 04, 2023 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
LeMaitre Vascular has been downgraded from Buy to Hold by Jefferies, but the price target has been raised from $63 to $67.
The downgrade from Buy to Hold suggests that Jefferies sees limited upside potential for LeMaitre Vascular in the short term. However, the raised price target indicates that they still see some growth potential. This could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100